menu
    • menu

    Company profile for NKMax

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    NKMAX was founded on the belief that ‘Health is the greatest wealth’. The company and its employees are committed to both improving quality of life and saving lives, whether by developing new immunotherapies, providing novel diagnostic tests, or providing the research community with research reagents that are crucial for life science advancements. NKMAX has developed the world ‘s first and only commercially available NK...
    NKMAX was founded on the belief that ‘Health is the greatest wealth’. The company and its employees are committed to both improving quality of life and saving lives, whether by developing new immunotherapies, providing novel diagnostic tests, or providing the research community with research reagents that are crucial for life science advancements. NKMAX has developed the world ‘s first and only commercially available NK Cell activity test. In addition, NKMAX provides high quality health supplements to help strengthen the immune system. NKMAX recently expanded its business to the cell therapy market.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    NKMaxkorearepublicofnew Flag
    Country
    Country
    South Korea
    Address
    Address
    1F/6F, SNUH Healthcare Innovation Park, 172, Dolma-ro, Bundang-gu, Seongnam-si...
    Telephone
    Telephone
    +82-31-8017-8114
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://nkmax.com/eng/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    Global ChemShow

    Not Confirmed

    envelop Contact Supplier

    Global ChemShow

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    NKMax Announces SNK01 Abstract Accepted for (SITC) 2021 Annual Meeting
    NKMax Announces SNK01 Abstract Accepted for (SITC) 2021 Annual Meeting

    04 Oct 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2021/10/04/2307863/0/en/NKMax-Announces-SNK01-Abstract-Accepted-for-Presentation-at-the-Society-for-Immunotherapy-of-Cancer-SITC-2021-Annual-Meeting.html

    GLOBENEWSWIRE
    04 Oct 2021
    Share Share
    NKMax Announces SNK01 Abstract Accepted for (SITC) 2021 Annual Meeting
    NKMax Announces SNK01 Abstract Accepted for (SITC) 2021 Annual Meeting

    04 Oct 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2021/10/04/2307863/0/en/NKMax-Announces-SNK01-Abstract-Accepted-for-Presentation-at-the-Society-for-Immunotherapy-of-Cancer-SITC-2021-Annual-Meeting.html

    GLOBENEWSWIRE
    04 Oct 2021
    Share Share
    NKMax, Merck expand clinical collaboration to include phase I/IIa trial of SNK01
    NKMax, Merck expand clinical collaboration to include phase I/IIa trial of SNK01

    14 Apr 2021

    // PHARMABIZ

    http://www.pharmabiz.com/NewsDetails.aspx?aid=137785&sid=2

    PHARMABIZ
    14 Apr 2021
    Share Share
    NKMax and Merck KGaA, Darmstadt, Germany Expand Clinical Collaboration
    NKMax and Merck KGaA, Darmstadt, Germany Expand Clinical Collaboration

    13 Apr 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2021/04/13/2209245/0/en/NKMax-and-Merck-KGaA-Darmstadt-Germany-Expand-Clinical-Collaboration-to-Include-Phase-I-IIa-Trial-Investigating-the-Combination-of-SNK01-with-ERBITUX-cetuximab-in-Metastatic-NSCLC.html

    GLOBENEWSWIRE
    13 Apr 2021
    Share Share
    NKMax America Announces Corporate Name Change to NKGen Biotech
    NKMax America Announces Corporate Name Change to NKGen Biotech

    02 Apr 2021

    // GLOBENEWSWIRE

    http://www.globenewswire.com/news-release/2021/04/02/2203854/0/en/NKMax-America-Announces-Corporate-Name-Change-to-NKGen-Biotech.html#:~:text=SANTA%20ANA%2C%20Calif.%2C%20April,which%20the%20Company%20believes%20best

    GLOBENEWSWIRE
    02 Apr 2021
    Share Share
    Affimed and NKMax America Announce FDA Clearance of IND Application to Study
    Affimed and NKMax America Announce FDA Clearance of IND Application to Study

    31 Mar 2021

    // PRESS RELEASE

    https://www.affimed.com/affimed-and-nkmax-america-announce-fda-clearance-of-ind-application-to-study-the-combination-of-afm24-an-egfr-targeted-innate-cell-engager-with-snk-01-natural-killer-cell-therapy-in-solid-tumors/

    PRESS RELEASE
    31 Mar 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search